Burlington, North Carolina-based LabCorp is rumored to be negotiating an $8 billion acquisition of Pharmaceutical Product Development (PPD), a global contract research organization operating in over ...

Digital clinical trials firm Medable is teaming up with Covance to allow the CRO to better navigate the COVID-19 disruption by using its virtual trial platform. Under the deal, financials of which ...

After months of rumors and amid a larger flurry of CRO M&A activity, LabCorp has bought out U.K. CRO Chiltern. Both have been on the M&A trail of late, with LabCorp buying CRO Covance in 2015 for $6 ...

Laboratory Corporation of America Holdings or LabCorp LH recently announced that it has completed its much talked-about swap transaction with Envigo, a provider of nonclinical contract research ...

BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that the new company to be formed by the planned spin-off of its Clinical Development ...

LabCorp, the Burlington-based life science conglomerate, is getting even bigger – with a bit of a North Carolina touch. In a deal disclosed early Monday, LabCorp says it is buying contract research ...

“We have an enormous database of patients, which includes their demographic information, their diagnosis information,” the WSJ reported LabCorp Chairman and Chief Executive Officer David King having ...

LabCorp® (NYSE:LH), a leading global life sciences company, and Chiltern, a specialty CRO, announced today that LabCorp will acquire Chiltern pursuant to a definitive agreement with Chiltern's ...

“Since LabCorp acquired Covance, we have grown the CRO business to nearly $3 billion in annual revenue,” said John Ratliff, CEO of Covance. “We now join with Chiltern to create a market-leading CRO, ...

Laboratory Corporation of America Holdings or LabCorp LH recently announced that it has completed its much talked-about swap transaction with Envigo, a provider of nonclinical contract research ...